$4.67M from Brain Canada will help probe the brain’s mysteries and create international research links
Research at The Neuro’s McConnell Brain Imaging Centre (BIC) of McGill University will receive a major boost thanks to a $4.67M grant from Brain Canada’s Platform Support Grant (PSG) program.
Research and Innovation and IT Services are pleased to welcome Marc Rousseau to the role of Director, Research Software / Directeur du Logiciel de Recherche. In this new role, Rousseau provides support and advice to the McGill research community on software, from grant applications to the implementation of research activities. He will also lead the development of the McGill Digital Research Services team, which will assist researchers in all fields of study with resources and tools in research data management (RDM), research software (RS) and advanced research computing (ARC).
TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement with McGill University for the exclusive use of Dr. Gabriella Gobbi's groundbreaking studies with lysergic acid diethylamide (LSD), its mechanism of action on the brain, and its potential for use at low doses in the treatment of mental health disorders.
SSHRC invests over $80k in new McGill research projects through the Partnership Engage Grants competition, two of which are directly related to COVID-19 research.
Recently, the Social Science and Humanities Research Council of Canada (SSHRC) announced the recipients of its latest competition of Partnership Engage Grants, as well as recipients of its Special Initiative COVID-19 grant competition. Four McGill researchers received funding through Partnership Engage grants for their projects, two of which received grants under the Special Initiative COVID-19 competition.
The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel-Giedion Syndrome (SGS). The international team of researchers is coordinated by the Douglas Research Centre and McGill’s Associate Professor and Canada Research Chair in Psychiatric Genetics, Carl Ernst. The EJP RD is a joint program between major funding bodies from over 25 countries, including the CIHR and FRQS.
HBHL and myPath invite you to register for the Peer Pathways Program!
In 2020, Dr. Alan Evans received the prestigious Killam Prize in Health Sciences for his innovative research in brain imaging and neuroinformatics.
Published in September 2020, Culture, Mind, and Brain: Emerging Concepts, Models, and Applications, provides insight into the connections between brain interactions and the cultural world around us. Through interdisciplinary perspectives from human, social, and biological sciences, this book explores how the unique biology and cultural diversity of individuals shapes behaviour and adaptation to a constantly evolving world.
Application Deadline: January 8, 2021
View the complete posting and apply
Join the HBHL team!
Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill’s relationship with Japan’s RIKEN institute.
By Junji Nishihata
HBHL is happy to announce new Leaders for Research Themes 1 and 4, as well as Associate Theme Leaders for all four of HBHL's research themes.
Application deadline: January 4, 2021
View the complete posting for Program Officer and apply.
Join the HBHL and NeuroSphere team!
Position Summary:
By Meaghan Thurston, Office of Research and Innovation
This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.
